주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Friday, March 29, 2024, 21:01
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
[Yuhan] First data update since last October
이미지기사
Company & Stock Tracking
Pyeongkuk Park
03.26 08:34
What’s Board Approval Rate of Samsung Electronics' Outside Directors Earning Over 200 Million Won Annually?
이미지기사
ICT
Kim Eun-jin
03.14 10:34
[NH Macro Strategy] New buying opportunity to emerge if market corrects after rally
이미지기사
Market Trend & Outlook
Lawrence Kim
02.29 12:51
[NH Macro Strategy] Market corrections in 1Q24 to offer dip buying opportunities
이미지기사
Market Trend & Outlook
Lawrence Kim
02.01 12:33
Pharmaceutical, Biotech Companies Gather in San Francisco
이미지기사
Healthcare & Bio
비지니스코리아 기자
01.05 10:57
[NH Macro Strategy] Will January Effect repeat?
이미지기사
Market Trend & Outlook
Lawrence Kim
2023.12.28 09:40
[Yuhan Corp] Internal sales estimate for amivantamab+lazertinib combo twice as high as consensus
이미지기사
Company & Stock Tracking
Pyeongkuk Park
2023.12.07 15:39
[2024 Outlook: Pharmaceutical/Bio industry] Companies with clear business models to survive
이미지기사
Market Trend & Outlook
Pyeongkuk Park
2023.11.21 11:03
[Yuhan Corp] MARIPOSA proves feasibility of first-line treatment
이미지기사
Company & Stock Tracking
Pyeongkuk Park
2023.10.25 09:49
Yuhan Pharmaceuticals Leclaza Triumphs: Approaching 7 Trillion Won Global Blockbuster
이미지기사
Healthcare & Bio
Jasmine Choi
2023.10.05 03:12
Spot Comment/Yuhan - Five things to watch for after phase III MARIPOSA success
이미지기사
Company & Stock Tracking
Pyeongkuk Park
2023.10.04 22:13
The next Yuhan
이미지기사
Company & Stock Tracking
Seungyeon Han
2023.09.27 15:09
Yuhan Corp. to Collaborate with Cyrus Therapeutics
이미지기사
Healthcare & Bio
Michael Herh
2023.09.06 18:49
Earnings beat consensus, but this is just the start
이미지기사
Finance
Pyeongkuk Park
2023.07.31 18:33
Korean-style Open Innovation Gains Traction as Domestic, Foreign Pharmaceutical Companies Team Up
이미지기사
Industries
Jasmine Choi
2023.07.31 08:33
Value of first-line NSCLC therapy far higher than expected
이미지기사
Finance
Pyeongkuk Park
2023.07.04 15:07
Yuhan Corporation Partners with J INTS BIO for 'HER2 Target TKI'
이미지기사
Industries
Jasmine Choi
2023.05.30 19:22
Expect earnings improvement and new drug momentum
이미지기사
Finance
Pyeongkuk Park
2023.04.10 17:51
Yuhan Corp.: Expect Leclaza-Rybrevant Concomitant Data This Year
이미지기사
Finance
Kim Tae-hee
2023.02.24 09:15
Yuhan: Laser301 Data Are Promising
이미지기사
Finance
Park Pyeong-kuk
2022.12.05 15:09
처음
1
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기